Europa Biosite
Europa Biosite, headquartered in Sweden, is a leading provider in the life sciences sector, specialising in innovative solutions for research and diagnostics. Founded in 2005, the company has established a strong presence across Europe, particularly in the Nordic region, and has made significant strides in the biotechnology industry. The firm offers a diverse range of core products and services, including high-quality antibodies, proteins, and assay kits, which are distinguished by their reliability and performance. Europa Biosite is recognised for its commitment to quality and customer service, positioning itself as a trusted partner for researchers and laboratories. With a focus on advancing scientific discovery, Europa Biosite has achieved notable milestones, including strategic partnerships and a growing portfolio of proprietary products. Its dedication to innovation and excellence has solidified its reputation as a key player in the life sciences market.
DitchCarbon Score
How does Europa Biosite's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Europa Biosite's score of 11 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Europa Biosite's reported carbon emissions
In 2023, Europa Biosite reported total carbon emissions of approximately 11,334,000 kg CO2e, with a breakdown across various scopes. The company’s Scope 1 emissions amounted to about 147,000 kg CO2e, while Scope 2 emissions were reported at approximately 85,000 kg CO2e (market-based) and 76,000 kg CO2e (location-based). The majority of emissions stemmed from Scope 3, which totalled around 11,340,000 kg CO2e. Significant contributors to Scope 3 emissions included purchased goods and services (approximately 10,121,000 kg CO2e) and upstream transportation and distribution (about 967,000 kg CO2e). Despite the substantial emissions figures, Europa Biosite has not disclosed any specific reduction targets or initiatives as part of their climate commitments. This lack of defined targets may reflect broader industry challenges in addressing carbon footprints. The company’s emissions data highlights the importance of developing comprehensive strategies to mitigate climate impact and align with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 147,000 |
| Scope 2 | 85,000 |
| Scope 3 | 11,334,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Europa Biosite is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
